Showing results (1971-1980 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|September 29, 2022
Soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1) and Natalizumab Serum Concentration as Potential Biomarkers for Pharmacodynamics and Treatment Response of Patients with Multiple Sclerosis Receiving NatalizumabMichael Auer, Angelika Bauer, Antonia Oftring, et al.CNS Drugs|September 30, 2022
Eslicarbazepine Acetate as Adjunctive Therapy for Primary Generalized Tonic-Clonic Seizures in Adults: A Prospective Observational StudyYaroslav Winter, Katharina Sandner, Thomas Ludger Vieth, et al.CNS Drugs|September 30, 2022
Bruton's Tyrosine Kinase Inhibitors in Multiple Sclerosis: Pioneering the Path Towards Treatment of Progression?Anastasia Geladaris, Sebastian Torke, Martin S WeberCNS Drugs|January 28, 2021
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An OverviewChristoph U Correll, Edward Kim, Jennifer Kern Sliwa, et al.CNS Drugs|March 13, 2021
Problem Gambling Associated with Aripiprazole: A Nested Case-Control Study in a First-Episode Psychosis ProgramOlivier Corbeil, Stéphanie Corbeil, Michel Dorval, et al.CNS Drugs|December 11, 2021
Impact of Natural Killer (NK) Cells on Immune Reconstitution, and Their Potential as a Biomarker of Disease Activity, in Alemtuzumab-Treated Patients with Relapsing Remitting Multiple Sclerosis: An Observational StudySerena Palmeri, Marta Ponzano, Federico Ivaldi, et al.CNS Drugs|November 18, 2021
Molecular Mechanisms of Psilocybin and Implications for the Treatment of DepressionSusan Ling, Felicia Ceban, Leanna M W Lui, et al.CNS Drugs|November 21, 2021
Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic PainFrank Petzke, Thomas Tölle, Mary-Ann Fitzcharles, et al.CNS Drugs|November 2, 2022
Evaluation of a Rapid Topiramate Titration Scheme for the Early Detection of Cognitive Side EffectsJuri-Alexander Witt, Guido Widman, Niels Hansen, et al.CNS Drugs|October 4, 2022
Targeting D-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of ResearchChien-Yi Kuo, Chieh-Hsin Lin, Hsien-Yuan LanePageof 211